BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 17486074)

  • 1. Overexpression of a transcription factor LYL1 induces T- and B-cell lymphoma in mice.
    Zhong Y; Jiang L; Hiai H; Toyokuni S; Yamada Y
    Oncogene; 2007 Oct; 26(48):6937-47. PubMed ID: 17486074
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Helix-loop-helix proteins LYL1 and E2a form heterodimeric complexes with distinctive DNA-binding properties in hematolymphoid cells.
    Miyamoto A; Cui X; Naumovski L; Cleary ML
    Mol Cell Biol; 1996 May; 16(5):2394-401. PubMed ID: 8628307
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Requirement for Lyl1 in a model of Lmo2-driven early T-cell precursor ALL.
    McCormack MP; Shields BJ; Jackson JT; Nasa C; Shi W; Slater NJ; Tremblay CS; Rabbitts TH; Curtis DJ
    Blood; 2013 Sep; 122(12):2093-103. PubMed ID: 23926305
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oncogenic potential of the transcription factor LYL1 in acute myeloblastic leukemia.
    Meng YS; Khoury H; Dick JE; Minden MD
    Leukemia; 2005 Nov; 19(11):1941-7. PubMed ID: 16094422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transcriptional deregulation of oncogenic myocyte enhancer factor 2C in T-cell acute lymphoblastic leukemia.
    Nagel S; Venturini L; Meyer C; Kaufmann M; Scherr M; Drexler HG; Macleod RA
    Leuk Lymphoma; 2011 Feb; 52(2):290-7. PubMed ID: 21261500
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple mechanisms induce ectopic expression of LYL1 in subsets of T-ALL cell lines.
    Nagel S; Venturini L; Meyer C; Kaufmann M; Scherr M; Drexler HG; MacLeod RA
    Leuk Res; 2010 Apr; 34(4):521-8. PubMed ID: 19608273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Physical interaction of the bHLH LYL1 protein and NF-kappaB1 p105.
    Ferrier R; Nougarede R; Doucet S; Kahn-Perles B; Imbert J; Mathieu-Mahul D
    Oncogene; 1999 Jan; 18(4):995-1005. PubMed ID: 10023675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TAL1, TAL2 and LYL1: a family of basic helix-loop-helix proteins implicated in T cell acute leukaemia.
    Baer R
    Semin Cancer Biol; 1993 Dec; 4(6):341-7. PubMed ID: 8142619
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lyl1 interacts with CREB1 and alters expression of CREB1 target genes.
    San-Marina S; Han Y; Suarez Saiz F; Trus MR; Minden MD
    Biochim Biophys Acta; 2008 Mar; 1783(3):503-17. PubMed ID: 18160048
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suspected leukemia oncoproteins CREB1 and LYL1 regulate Op18/STMN1 expression.
    San-Marina S; Han Y; Liu J; Minden MD
    Biochim Biophys Acta; 2012; 1819(11-12):1164-72. PubMed ID: 23000483
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proviral activation of the tumor suppressor E2a contributes to T cell lymphomagenesis in EmuMyc transgenic mice.
    Mikkers H; Allen J; Berns A
    Oncogene; 2002 Sep; 21(43):6559-66. PubMed ID: 12242653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SCL, LMO1 and Notch1 reprogram thymocytes into self-renewing cells.
    Gerby B; Tremblay CS; Tremblay M; Rojas-Sutterlin S; Herblot S; Hébert J; Sauvageau G; Lemieux S; Lécuyer E; Veiga DF; Hoang T
    PLoS Genet; 2014 Dec; 10(12):e1004768. PubMed ID: 25522233
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiopoietin-2 is a direct transcriptional target of TAL1, LYL1 and LMO2 in endothelial cells.
    Deleuze V; El-Hajj R; Chalhoub E; Dohet C; Pinet V; Couttet P; Mathieu D
    PLoS One; 2012; 7(7):e40484. PubMed ID: 22792348
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tal1 transgenic expression reveals absence of B lymphocytes.
    Palamarchuk A; Zanesi N; Aqeilan RI; Efanov A; Maximov V; Santanam U; Hagan JP; Croce CM; Pekarsky Y
    Cancer Res; 2006 Jun; 66(12):6014-7. PubMed ID: 16778172
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The DNA binding activity of TAL-1 is not required to induce leukemia/lymphoma in mice.
    O'Neil J; Billa M; Oikemus S; Kelliher M
    Oncogene; 2001 Jun; 20(29):3897-905. PubMed ID: 11439353
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of a pediatric T-cell acute lymphoblastic leukemia patient with simultaneous LYL1 and LMO2 rearrangements.
    Homminga I; Vuerhard MJ; Langerak AW; Buijs-Gladdines J; Pieters R; Meijerink JP
    Haematologica; 2012 Feb; 97(2):258-61. PubMed ID: 22058201
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel role for
    Chiu SK; Saw J; Huang Y; Sonderegger SE; Wong NC; Powell DR; Beck D; Pimanda JE; Tremblay CS; Curtis DJ
    Development; 2018 Oct; 145(19):. PubMed ID: 30185409
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adult hematopoietic stem and progenitor cells require either Lyl1 or Scl for survival.
    Souroullas GP; Salmon JM; Sablitzky F; Curtis DJ; Goodell MA
    Cell Stem Cell; 2009 Feb; 4(2):180-6. PubMed ID: 19200805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enforced expression of E47 has differential effects on Lmo2-induced T-cell leukemias.
    Goodings C; Tripathi R; Cleveland SM; Elliott N; Guo Y; Shyr Y; Davé UP
    Leuk Res; 2015 Jan; 39(1):100-9. PubMed ID: 25499232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Advances of lymphoblastic lymphoma and its molecular genetics].
    Pan Y; Li GD; Liu WP
    Zhonghua Bing Li Xue Za Zhi; 2005 Apr; 34(4):236-9. PubMed ID: 16091181
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.